Aspire Health Review
Best for: compounded + brand GLP-1s (Wegovy/Zepbound) with labs included and named PA/NP team in Nebraska telehealth
Aspire Health is a Nebraska-based telehealth practice offering both compounded semaglutide/tirzepatide (formulated with B6) and brand-name Wegovy and Zepbound, prescribed by a named PA/NP clinical team. The LoseIt membership ($200 enrollment + $75/month) includes lab orders with interpretation, provider visits every 2–3 months, Slimpossible app access, and ongoing support — with medication billed separately starting at $149 per 5-week supply for compounded semaglutide.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Included
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Aspire Health is a solid telehealth option with balanced features and pricing.
Aspire Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded Semaglutide, Compounded Tirzepatide, Wegovy (Brand), Zepbound (Brand)
- Starting price
- $205/mo (Verbatim from weight-loss page: '$149' for 5-week supply of compounded semaglutide/B6 (low dose 0.25–0.5 mg) + $75/month LoseIt program fee = ~$205/month total. 'Medication costs are not included in either program fee.' 15-week supply listed at $399 (~$115/mo for medication alone). program fee enrollment fee $200 ($175 online).)
- What's included
- Medication · Consult · Labs · Shipping · Coaching
- FDA status
- No FDA warning letter on record
How we scored Aspire Health
Each dimension is scored algorithmically from Aspire Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.3/10At $205/mo, Aspire Health runs about 21% above the $170 median for GLP-1 providers.
Effectiveness25%
7.9/10Aspire Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.3/10Online intake and platform experience — app/portal-based, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-04).
Accessibility10%
6.0/10Aspire Health's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.7/10Coaching/dietitian access included.
How we verified this Aspire Health review
Last checked 2026-07-04- Confirmed current pricing across 6 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Aspire Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Verbatim from weight-loss page: '$149' for 5-week supply of compounded semaglutide/B6 (low dose 0.25–0.5 mg) + $75/month LoseIt program fee = ~$205/month total. 'Medication costs are not included in either program fee.' 15-week supply listed at $399 (~$115/mo for medication alone). program fee enrollment fee $200 ($175 online).
Verbatim from weight-loss page: '$199' for 5-week supply of compounded semaglutide/B6 (high dose 1.7+ mg) + $75/month LoseIt program fee = ~$247/month total. 15-week supply listed at $499 (~$144/mo for medication alone). 'Medication costs are not included in either program fee.'
Verbatim from weight-loss page: '$199' for 4-week supply of Wegovy (brand semaglutide, starter doses) + $75/month LoseIt program fee = ~$274/month total. Other Wegovy doses listed at $399/4 weeks (~$474/mo total with program fee). 'Medication costs are not included in either program fee.'
Verbatim from weight-loss page: '$249' for 5-week supply of compounded tirzepatide/B6 (2.5 mg) + $75/month LoseIt program fee = ~$289/month total. 15-week supply at $699 (~$202/mo for medication alone). 'Medication costs are not included in either program fee.'
Verbatim from weight-loss page: '$349' for 5-week supply of compounded tirzepatide/B6 (5–15 mg) + $75/month LoseIt program fee = ~$375/month total. 15-week supply at $999 (~$289/mo for medication alone). 'Medication costs are not included in either program fee.'
Verbatim from weight-loss page: '$299' for 4-week supply of Zepbound (brand tirzepatide, 2.5 mg) + $75/month LoseIt program fee = ~$374/month total. Higher doses (7.5–15 mg) listed at $449/4wks (~$524/mo total with program fee). 'Medication costs are not included in either program fee.'
Ready to get started?
Plans and promotions change often — check Aspire Health's current pricing and active discounts before you decide.
What we like
- Both compounded and brand-name options (Wegovy + Zepbound) — rare among GLP-1 telehealth providers
- Lab orders with interpretation included in LoseIt membership — not billed separately
- Named clinical team: founded by Jenni Haan, MPAS, PA-C (18+ years experience) with four additional credentialed providers
- Slimpossible app + secure messaging for ongoing support between provider visits
- HSA/FSA accepted; Cherry third-party financing available for patients needing payment plans
Watch-outs
- Membership fee ($75/month) stacks on top of separately billed medication — total spend $205–$524/month depending on dose
- No LegitScript certification or independent third-party accreditation disclosed
- States served not publicly listed; availability depends on individual provider licensure
- All medication sales are final once shipped; consultation fee non-refundable once completed
- Compounding pharmacy partner not named on any public page
Is Aspire Health worth it? Our verdict
Aspire Health positions itself around one thing: compounded + brand GLP-1s (Wegovy/Zepbound) with labs included and named PA/NP team in Nebraska telehealth. It runs $205/month — a premium to the category, so the extras need to justify it. Coaching and follow-up are part of the package, not an upsell.
What gives Aspire Health its own flavor: Compounded Semaglutide, Compounded Tirzepatide, and Wegovy (Brand).
How much Aspire Health actually costs
- Compounded semaglutide — $205/month
- Compounded semaglutide — $247/month
- Brand-name semaglutide — $274/month
- Compounded tirzepatide — $289/month
- Compounded tirzepatide — $375/month
- Brand-name tirzepatide — $374/month
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so Aspire Health's standing rate sits at the premium end.
For a direct comparison, Breeze Meds runs semaglutide and tirzepatide from $199/month — worth pricing against Aspire Health before you commit.
Medications: what Aspire Health prescribes
Aspire Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.
Who Aspire Health is best for — and who should skip it
A good fit if you…
- want coaching and follow-up included, not sold separately.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Aspire Health costs more than the budget end of the market, so it makes the most sense if its specific extras matter to you. If they don't, you can likely get the same medication for less elsewhere.
Ready to start with Aspire Health?
Starting at $205/month. See current pricing and start your free consultation.
Alternatives to Aspire Health
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Aspire Health review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Aspire Health?
Starting at $205/month. See current pricing and start your free consultation.